Petronas Chemicals stock reports stronger second-quarter profit

Published on 10/07/2026 at 07:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Petronas Chemicals stock delivered MYR 445 million in Q2 2026 PAT, up from MYR 427 million a year earlier. Revenue reached MYR 7.903 billion, while the average analyst target was MYR 5.13.

Petronas Chemicals, MYL5183OO008, Illustration mit AI erstellt.

Petronas Chemicals stock (ISIN MYL5183OO008) was trading at MYR 4.30 on Bursa Malaysia on October 7, 2026, while the company reported second-quarter 2026 PAT of MYR 445 million. The result compared with MYR 427 million in the first quarter of 2026, according to PETRONAS Chemicals.

Revenue reaches MYR 7.903 billion

Revenue reached MYR 7.903 billion in Q2 2026, up from MYR 7.015 billion in Q1 2026. That is a 12.7 percent sequential increase, while EBITDA declined to MYR 1.057 billion from MYR 1.278 billion, according to PETRONAS Chemicals.

The company also reported Q2 2026 net income of MYR 414 million in standardized financial statements, compared with MYR 401 million in Q1 2026. The difference between net income and PAT reflects the use of different profit measures, so the figures should not be treated as interchangeable.

Analyst target stays above the stock

The analyst picture remains divided after the recent sector rally. According to Investing.com, 19 analysts give Petronas Chemicals a Buy consensus, with 9 Buy, 6 Hold and 4 Sell ratings.

The same consensus puts the average 12-month target at MYR 5.13, with a high of MYR 6.90 and a low of MYR 3.60. Against the MYR 4.30 Bursa price on October 7, 2026, the average target lies 19.3 percent above the stock price, creating a clear gap between current trading and analyst expectations.

Stock sits inside its yearly range

Petronas Chemicals had a market capitalization of MYR 34.4 billion and volume of 778,100 shares on October 7, 2026. Its 52-week range was MYR 2.83 to MYR 6.16, placing the MYR 4.30 price 30.2 percent below the yearly high.

For investors, the key tension is visible in the operating figures: Q2 revenue increased 12.7 percent from Q1, but EBITDA fell 17.3 percent over the same comparison. The stock therefore combines improving sales with a lower quarterly EBITDA base.